Cardiovascular Research Foundation releases schedule for CTO Summit
The Cardiovascular Research Foundation announced that the Chronic Total Occlusion (CTO) Summit is taking place Feb. 23 and 24 at the New York Marriott Marquis.
The conference will feature sessions on selecting the right patients for CTOs, showcase live cases and provide insights on the basics of the procedure and how to deal with complications. It will also have a session on the latest research in the field.
Here is a list of the topics discussed at the session titled, “Data From Around the Globe and Controversies,” which is on Feb. 24 in the hotel’s Broadway ballroom. (All times are Eastern Standard Time):
- 4:30 p.m. – Update From The Collagenase Study – presenter is Bradley H. Strauss, MD, PhD, of Sunnybrook Health Sciences Center in Toronto.
- 4:40 p.m. – The EURO CTO Trial: What to Expect? – Gerald S. Werner, MD, of Klinikum Darmstadt in Darmstadt, Germany.
- 4:50 p.m. – Progress CTO Registry Update – Emmanouil S. Brilakis, MD, of the Minneapolis Heart Institute in Minneapolis.
- 5:00 p.m. – Improving Exercise Capacity With CTO PCI – Kambis Mashayekhi, MD, of University Heartcenter Bad Krozingen in Bad Krozingen, Germany.
- 5:10 p.m. – Open CTO Registry Update – J. Aaron Grantham, MD, of the University of Missouri Kansas City and Saint Luke's Mid America Heart Institute in Kansas City, Missouri.
- 5:20 p.m. – Data From the RECHARGE Registry – Simon J. Walsh, MD, of Belfast Trust in Belfast, United Kingdom.
- 5:30 p.m. – Data From the PERSPECTIVE Registry – David E. Kandzari, MD, of the Piedmont Heart Institute in Atlanta.
- 5:40 p.m. – A Japanese Registry Update: J-PROCTOR 2 – Etsuo Tsuchikane, MD, PhD, of the Toyohashi Heart Center in Toyohashi, Japan.
- 5:50 p.m. – Assessment of Ischemia in CTOs – Paul Knaapen, MD, PhD, of VU University Medical Center in Amsterdam, The Netherlands.
- 6:00 p.m. – BVS in CTOs: Current Experience – Mauro Carlino, MD, of San Raffaele Hospital in Milan, Italy.
- 6:08 p.m. – Three Year Outcomes From the EXPERT CTO Trial – David E. Kandzari, MD, of the Piedmont Heart Institute in Atlanta.